Company intelligence / Profile preview

S2 ScienceSolutions

Vienna, Vienna, Austriaclinicaltrialsarena.com ↗

Ownership: Private
Development stage: Other

Overview

S2 ScienceSolutions is an Austria-based contract research organization with over 20 years of experience managing Phase I–IV clinical trials in the pharmaceutical, biotechnology, and medical device sectors. The company has expertise in vigilance and quality assurance services. In 2024 it was acquired by SanaClis to strengthen their presence in the DACH region and expand global end-to-end clinical trial capabilities. The founding partner Katharina Glaninger-Ullmann continues to lead the team post-acquisition.

Industry: Contract Research Organization

Partnerships

Previously collaborated with SanaClis before acquisition

Beyond the preview

Go deeper on S2 ScienceSolutions.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on S2 ScienceSolutions.

Explore the full profile